Molina Healthcare Reports First Quarter 2016 Results

Go back to Molina Healthcare Reports First Quarter 2016 Results

UBS Downgrades Molina Healthcare (MOH) to Neutral

April 29, 2016 7:19 AM EDT

UBS downgraded Molina Healthcare (NYSE: MOH) from Buy to Neutral with a price target of $54.00 (from $76.00) following Q1 miss and lower guidance.

Analyst A.J. Rice commented, "Our MOH thesis has been based on two tenets: 1) a clear path to a... More

Molina Healthcare (MOH) Sinks After Missing Q1, Guiding Lower

April 28, 2016 5:57 PM EDT

Molina Healthcare (NYSE: MOH) is down 12% after-hours after the company reported Q1 EPS of $0.51, $0.31 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $4 million versus the consensus estimate of $4.17 billion.

Although first quarter results were not in line with our... More